A new guideline from AGA and the Joint Task Force for Allergy-Immunology Practice Parameters provides recommendations for the management of EoE in pediatric and adult patients.
Key guideline highlights:
- Topical steroids are recommended as a first-line treatment for EoE.
- The guideline also recommends proton pump inhibition (PPI) therapy, diet therapy and esophageal dilation as treatment options.
- The use of novel, targeted biologic therapies for EoE are being actively evaluated and more research is needed before these can be recommended.
Review the guideline for the complete recommendations.
This guideline was developed through a collaboration between AGA and the Joint Task Force for Allergy-Immunology Practice Parameters, which comprises the American Academy of Allergy, Asthma & Immunology and the American College of Allergy, Asthma & Immunology. This guideline is jointly published in Gastroenterology and Annals of Allergy, Asthma and Immunology.